Related references
Note: Only part of the references are listed.Outcomes and prognostic variables of extracranial germ cell tumors in children and adolescents treated over a decade: A developing world perspective
Subramaniam Ramanathan et al.
PEDIATRIC BLOOD & CANCER (2022)
Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience
Maria Debora De Pasquale et al.
PEDIATRIC BLOOD & CANCER (2020)
Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study
Farzana Pashankar et al.
PEDIATRIC BLOOD & CANCER (2018)
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience
Nabil Adra et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration
Thomas A. Olson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience
Christos Kosmas et al.
ANTI-CANCER DRUGS (2014)
Salvage Therapy for Refractory or Recurrent Pediatric Germ Cell Tumors: The French SFCE Experience
Cecile Faure-Conter et al.
PEDIATRIC BLOOD & CANCER (2014)
Is High Dose Therapy Superior to Conventional Dose Therapy as Initial Treatment for Relapsed Germ Cell Tumors? The TIGER Trial
Darren R. Feldman et al.
JOURNAL OF CANCER (2011)
TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis
Darren R. Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
Joerg Beyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors
Lawrence H. Einhorn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: A prospective randomized multicenter trial of the German Testicular Cancer Study Group
Anja Lorch et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A population-based study evaluating metastatic renal cell cancer (mRCC) patients treated with interferon (IFN) alone, first-line IFN then second-line sunitinib, or sunitinib alone
C. K. Kollmannsberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
GV Kondagunta et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours
U De Giorgi et al.
BRITISH JOURNAL OF CANCER (2005)
Treatment of recurrent malignant sacrococcygeal germ cell tumors:: Analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96
DT Schneider et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
The United Kingdom Children's Cancer Study Group's second germ cell tumor study: Carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity
JR Mann et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
